SCHEMBL19976815

SCHEMBL19976815

CCOCCN/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2ccc(C(F)(F)F)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.44
TRPA1 O75762 3/20 0.41
MAPK1 P28482 4/20 0.40
HDAC6 Q9UBN7 1/20 0.40
MAP2K4 P45985 3/20 0.39
MAPK6 Q16659 2/20 0.39
MAPKAPK3 Q16644 1/20 0.39
CCR2 P41597 2/20 0.39
KCNH2 Q12809 2/20 0.39
NTRK1 P04629 1/20 0.39
MAPK8 P45983 2/20 0.36
MAPK10 P53779 1/20 0.36
MAPKAPK5 Q8IW41 2/20 0.36
PLK4 O00444 1/20 0.36
MAPK13 O15264 1/20 0.36
DAPK3 O43293 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
CDK1 P06493 1/20 0.36
PIM1 P11309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976812 0.94 GSK3B (0.51) GSK3BTRPA1MAPK1HDAC6MAP2K4
SCHEMBL19976828 0.91 GSK3B (0.49) GSK3BTRPA1MAPK1HDAC6MAP2K4
SCHEMBL19976731 0.88 MAPK1 (0.42) GSK3BMAPK1HDAC6NTRK1MAPK8
SCHEMBL19976800 0.88 GSK3B (0.43) GSK3BTRPA1MAPK1HDAC6MAP2K4
SCHEMBL19976907 0.87 GSK3B (0.49) GSK3BTRPA1MAPK1HDAC6MAP2K4
SCHEMBL19976858 0.86 MAPK1 (0.46) GSK3BMAPK1HDAC6MAP2K4MAPK6
SCHEMBL19976763 0.85 GSK3B (0.52) GSK3BTRPA1MAPK1HDAC6MAP2K4
SCHEMBL19976764 0.85 GSK3B (0.48) GSK3BTRPA1MAPK1HDAC6MAP2K4
SCHEMBL19976854 0.85 GSK3B (0.42) GSK3BTRPA1MAPK1HDAC6MAP2K4
SCHEMBL19976753 0.84 GSK3B (0.47) GSK3BTRPA1MAPK1HDAC6MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed